The US Food and Drug Administration (FDA) has recently rolled back certain regulatory requirements for lab-developed tests (LDTs), a decision that has sparked renewed discussions about clinical ivermectin studies 2025 usa , patient safety, regulatory accountability, and drug access. While LDTs ​​were previously held to strict FDA oversight standards, the rollback now allows...